TOOKAD®Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer

Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study

(2012) Hashim U Ahmed et al.   LANCET ONCOLOGY

Radical Prostatectomy versus Observation for Localized Prostate Cancer

(2012) Timothy J. Wilt et al.   NEW ENGLAND JOURNAL OF MEDICINE

A model to estimate the outcome of prostate cancer photodynamic therapy with TOOKAD Soluble WST11

(2011) Nacim Betrouni et al.   PHYSICS IN MEDICINE AND BIOLOGY

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease

(2010) Axel Heidenreich et al.   EUROPEAN UROLOGY

Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer

(2010) Matthew R. Cooperberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Permanent Occlusion of Feeding Arteries and Draining Veins in Solid Mouse Tumors by Vascular Targeted Photodynamic Therapy (VTP) with Tookad

(2010) Noa Madar-Balakirski et al.   PLoS One

Active Surveillance for Prostate Cancer: A Review

(2010) Laurence Klotz   Current Urology Reports

Quality of life outcomes following treatment for localized prostate cancer: is there a clear winner?

(2009) Walter R Parker et al.   CURRENT OPINION IN UROLOGY

Photocatalytic Generation of Oxygen Radicals by the Water-Soluble Bacteriochlorophyll Derivative WST11, Noncovalently Bound to Serum Albumin

(2009) Idan Ashur et al.   JOURNAL OF PHYSICAL CHEMISTRY A

Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses

(2008) John Trachtenberg et al.   BJU INTERNATIONAL